The Effects of ∆-9-THC and Naloxone in Humans



Status:Active, not recruiting
Conditions:Healthy Studies
Therapuetic Areas:Other
Healthy:No
Age Range:18 - 55
Updated:1/11/2019
Start Date:July 2011
End Date:January 2020

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Assessment of Cannabinoid-opiate Interactions in Humans With a Cannabis Use Disorder and Healthy Subjects

The purpose of this project is to examine the effects of mu-opiate antagonism on the
rewarding and reinforcing effects of delta-9-tetrahydrocannabinol (THC), the main
psychoactive ingredient of cannabis.


Inclusion Criteria:

- At least one exposure to Cannabis

Exclusion Criteria:

- Cannabis Naive
We found this trial at
1
site
VA Connecticut Healthcare System
950 Campbell Ave
West Haven, Connecticut 06516
(203) 932-5711
Principal Investigator: Deepak D'Souza, M.D.
Phone: 203-932-5711
VA Connecticut Healthcare System VA Connecticut encompasses an inpatient facility and Ambulatory Care Center in...
?
mi
from
West Haven, CT
Click here to add this to my saved trials